Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
MNDR	MOBILE-HEALTH NETWORK SOLUTIONS	Cayman Islands	N/A	34,000,000	0.00%	0.00%
RAPT	RAPT THERAPEUTICS INC	United States	$141.01M	34,903,476	64.22%	35.78%	Net Selling
GOSS	GOSSAMER BIO INC	United States	$157.00M	226,218,652	85.80%	14.20%	Net Buying	Net Selling
IMUX	IMMUNIC INC	Germany	$112.15M	90,079,016	63.65%	17.15%	Net Buying	Net Buying
CDXS	CODEXIS INC	United States	$254.71M	70,557,577	46.15%	53.85%	Net Buying
TLIS	TALIS BIOMEDICAL CORP	United States	$34.24M	3,813,067	20.78%	76.74%
AWH	ASPIRA WOMEN's HEALTH INC	United States	$33.12M	12,449,512	2.19%	97.81%	Net Buying
ARAY	ACCURAY INC	United States	$161.77M	99,244,173	60.19%	39.81%	Net Selling	Net Selling
GBIO	GENERATION BIO CO	United States	$243.50M	66,528,840	64.26%	35.74%	Net Buying	Net Selling
IBIO	IBIO INC	United States	$17.07M	8,623,676	6.21%	93.79%	Net Selling
MNMD	MIND MEDICINE (MINDMED) INC	Canada	$590.79M	71,872,422	44.27%	55.73%	Net Selling	Net Selling
MNPR	MONOPAR THERAPEUTICS	United States	$10.67M	17,484,175	1.91%	98.09%	Net Selling	Net Selling
DAWN	DAY ONE BIOPHARMACEUTICALS INC	United States	$1.41B	87,389,859	53.37%	46.63%	Net Buying	Net Selling
REPL	REPLIMUNE GROUP INC	United States	$395.51M	61,415,105	67.89%	32.11%	Net Selling
BJDX	BLUEJAY DIAGNOSTICS INC	United States	$1.68M	2,904,448	3.10%	96.90%	Net Buying
PRLD	PRELUDE THERAPEUTICS INC	United States	$219.72M	54,929,567	52.06%	47.94%	Net Buying	Net Selling
CTXR	CITIUS PHARMACEUTICALS INC	United States	$117.08M	180,673,355	14.89%	6.81%
ATNM	ACTINIUM PHARMACEUTICALS INC	United States	$291.88M	29,783,451	17.50%	82.50%
ELAB	ELEVAI LABS INC	United States	$12.94M	18,892,115	0.28%	94.38%
ONCY	ONCOLYTICS BIOTECH INC	Canada	$83.72M	75,419,768	1.78%	0.00%
GNPX	GENPREX INC	United States	$5.35M	2,098,698	2.56%	97.44%	Net Selling
OMCL	OMNICELL INC	United States	$1.40B	45,923,492	95.22%	4.78%	Net Selling	Net Selling
INGN	INOGEN INC	United States	$208.19M	23,577,109	73.05%	26.95%	Net Selling	Net Selling
XYLO	XYLO TECHNOLOGIES LTD	Israel	$3.58M	27,989,465	0.01%	0.00%
ASRT	ASSERTIO HOLDINGS INC	United States	$101.78M	95,124,605	45.89%	20.42%	Net Selling	Net Selling
SXTC	CHINA SXT PHARMACEUTICALS INC	China	$837.03k	727,851	0.39%	0.00%
OGEN	ORAGENICS INC	United States	$10.44M	4,480,693	0.41%	99.59%	Net Selling
BFRI	BIOFRONTERA INC	United States	$5.45M	5,089,413	11.52%	88.48%
BBLG	BONE BIOLOGICS CORP	United States	$2.07M	1,100,489	0.62%	99.38%	Net Buying
RPHM	RENEO PHARMACEUTICALS INC	United States	$58.49M	33,420,808	58.60%	41.40%	Net Buying	Net Buying
XRTX	XORTX THERAPEUTICS INC	Canada	$7.26M	2,903,565	0.57%	0.00%
AMRN	AMARIN CORP PLC	Ireland	$357.46M	410,868,659	21.49%	15.40%	Net Selling
VIRI	VIRIOS THERAPEUTICS INC	United States	$6.76M	19,257,937	3.52%	5.34%	Net Buying
CAPR	CAPRICOR THERAPEUTICS INC	United States	$197.23M	31,811,470	13.18%	86.82%	Net Buying	Net Buying
ALLK	ALLAKOS INC	United States	$127.50M	88,544,474	47.45%	52.55%	Net Selling	Net Selling
ATHA	ATHIRA PHARMA INC	United States	$96.59M	38,328,652	56.60%	31.41%	Net Buying
ALXO	ALX ONCOLOGY HOLDINGS INC	United States	$740.34M	52,100,107	75.65%	24.35%	Net Selling	Net Selling
GRI	GRI BIO INC	United States	$1.59M	3,774,488	6.21%	72.87%
CALC	CALCIMEDICA INC	United States	$58.58M	10,749,065	13.65%	86.35%	Net Buying	Net Buying
WVE	WAVE LIFE SCIENCES LTD	Singapore	$766.60M	122,460,160	61.24%	38.76%	Net Buying	Net Selling
ELEV	ELEVATION ONCOLOGY INC	United States	$197.24M	54,638,262	78.87%	21.13%	Net Selling	Net Selling
DYN	DYNE THERAPEUTICS INC	United States	$2.42B	87,382,638	72.40%	27.60%	Net Selling	Net Selling
BLTE	BELITE BIO INC	United States	$1.31B	29,149,444	0.20%	0.00%
ADVM	ADVERUM BIOTECHNOLOGIES INC	United States	$166.89M	20,756,850	40.55%	59.45%	Net Buying
TNON	TENON MEDICAL INC	United States	$3.18M	3,729,474	15.11%	83.03%	Net Buying
APM	APTORUM GROUP LTD	China	$24.61M	5,181,697	1.12%	40.28%
ALVR	ALLOVIR INC	United States	$89.13M	115,003,325	16.77%	83.23%	Net Buying	Net Selling
SHLT	SHL TELEMEDICINE LTD	Israel	$83.60M	16,392,754	3.86%	0.00%
OPT	OPTHEA LTD	Australia	$199.13M	467,159,374	1.43%	0.00%
LUCD	LUCID DIAGNOSTICS INC	United States	$47.16M	52,114,353	3.91%	67.19%	Net Buying
MBOT	MICROBOT MEDICAL INC	United States	$13.54M	14,398,964	4.35%	95.65%
TNYA	TENAYA THERAPEUTICS INC	United States	$365.89M	78,517,534	59.53%	40.47%	Net Buying	Net Selling
QNRX	QUOIN PHARMACEUTICALS LTD	Israel	$3.02M	3,979,970	0.01%	99.99%
MCRB	SERES THERAPEUTICS INC	United States	$139.33M	151,447,763	56.51%	30.05%	Net Selling
TSHA	TAYSHA GENE THERAPIES INC	United States	$577.89M	187,018,275	74.94%	15.93%	Net Buying
DERM	JOURNEY MEDICAL CORP	United States	$69.04M	20,012,896	9.06%	15.76%	Net Buying	Net Buying
AVTE	AEROVATE THERAPEUTICS INC	United States	$592.59M	28,808,334	66.64%	33.36%	Net Selling	Net Selling
BDRX	BIODEXA PHARMACEUTICALS PLC	United Kingdom	$6.07M	1,699,804,122	0.00%	0.00%
COSM	COSMOS HEALTH INC	Greece	$9.28M	13,404,204	4.51%	11.88%	Net Buying
ICUI	ICU MEDICAL INC	United States	$2.53B	24,365,990	69.05%	30.95%	Net Selling	Net Selling
IONS	IONIS PHARMACEUTICALS INC	United States	$5.45B	145,965,374	96.26%	3.74%	Net Selling	Net Buying
EBS	EMERGENT BIOSOLUTIONS INC	United States	$290.83M	52,401,850	42.47%	57.53%	Net Selling	Net Selling
INFU	INFUSYSTEM HOLDINGS INC	United States	$137.14M	21,295,254	26.54%	73.46%	Net Selling	Net Selling
TSVT	2SEVENTY BIO INC	United States	$246.75M	51,405,419	64.50%	35.50%	Net Buying	Net Buying
SYRE	SPYRE THERAPEUTICS INC	United States	$1.52B	40,283,414	55.65%	44.35%	Net Buying
BIOR	BIORA THERAPEUTICS INC	United States	$26.20M	35,883,843	10.56%	89.44%	Net Selling
VNRX	VOLITIONRX LTD	United States	$63.77M	82,815,121	9.40%	39.76%	Net Buying	Net Selling
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	United States	$2.85B	251,924,898	35.23%	64.77%	Net Selling	Net Selling
GRTS	GRITSTONE BIO INC	United States	$85.44M	108,569,374	43.16%	20.10%	Net Buying
OFIX	ORTHOFIX MEDICAL INC	United States	$562.94M	37,529,256	87.68%	12.32%	Net Buying	Net Selling
ONCT	ONCTERNAL THERAPEUTICS INC	United States	$25.63M	2,959,645	0.79%	99.21%	Net Selling	Net Buying
ALNY	ALNYLAM PHARMACEUTICALS INC	United States	$18.90B	126,491,778	80.26%	19.74%	Net Selling	Net Selling
POAI	PREDICTIVE ONCOLOGY INC	United States	$6.89M	4,101,776	0.16%	99.84%	Net Selling
VVOS	VIVOS THERAPEUTICS INC	United States	$7.39M	3,227,270	1.97%	98.03%	Net Buying
NRBO	NEUROBO PHARMACEUTICALS INC	United States	$22.86M	4,906,002	0.37%	99.63%
CARM	CARISMA THERAPEUTICS INC	United States	$58.58M	41,542,744	20.48%	74.42%
XNCR	XENCOR INC	United States	$1.42B	61,662,550	67.16%	32.84%	Net Buying	Net Selling
AIM	AIM IMMUNOTECH INC	United States	$20.67M	51,281,437	7.98%	9.84%	Net Buying	Net Buying
FLGC	FLORA GROWTH CORP	United States	$16.79M	12,816,535	2.78%	57.12%	Net Buying	Net Buying
FRES	FRESH2 GROUP LTD	China	$4.27M	179,643,565	0.00%	38.84%
FHTX	FOGHORN THERAPEUTICS INC	United States	$234.65M	42,585,616	62.13%	18.76%	Net Selling	Net Selling
MDXH	MDXHEALTH SA	Belgium	$7.86M	27,288,093	11.51%	88.49%
CYCC	CYCLACEL PHARMACEUTICALS INC	United States	$3.35M	1,463,259	0.80%	99.20%	Net Buying
GEHC	GE HEALTHCARE TECHNOLOGIES INC	United States	$37.37B	456,465,369	79.93%	7.45%	Net Selling	Net Selling
SYRA	SYRA HEALTH CORP	United States	$10.21M	6,421,632	1.41%	10.80%	Net Buying
BLCO	BAUSCH & LOMB CORP	Canada	$5.15B	351,482,100	9.34%	88.95%	Net Selling	Net Selling
INMB	INMUNE BIO INC	United States	$214.64M	19,782,429	13.85%	37.05%	Net Buying	Net Buying
CGEN	COMPUGEN LTD	Israel	$186.56M	88,415,382	14.22%	0.00%
NOTV	INOTIV INC	United States	$50.12M	25,971,450	25.19%	43.41%	Net Buying
CYTH	CYCLO THERAPEUTICS INC	United States	$40.06M	28,615,740	3.12%	96.88%	Net Buying
SNGX	SOLIGENIX INC	United States	$6.21M	15,799,837	0.23%	99.77%
AUNA	AUNA SA	Luxembourg	N/A	73,917,577	12.89%	0.00%
SINT	SINTX TECHNOLOGIES INC	United States	$10.43M	122,698,454	0.95%	2.34%
PHG	KONINKLIJKE PHILIPS NV	Netherlands	$25.36B	906,403,156	7.60%	0.00%
VTRS	VIATRIS INC	United States	$13.07B	1,190,675,819	79.71%	17.86%	Net Selling	Net Selling
ALIM	ALIMERA SCIENCES INC	United States	$167.64M	52,388,513	28.94%	71.06%	Net Buying	Net Selling
CTSO	CYTOSORBENTS CORP	United States	$52.57M	54,306,415	32.28%	50.28%	Net Buying
QDEL	QUIDELORTHO CORP	United States	$2.87B	66,971,816	73.79%	26.21%	Net Selling	Net Buying
INDV	INDIVIOR PLC	United Kingdom	$2.32B	136,526,357	47.78%	0.00%
SENS	SENSEONICS HOLDINGS INC	United States	$257.48M	530,886,421	12.32%	37.35%	Net Selling	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.